New blood pressure gadget put to the test in pregnancy
NCT ID NCT06002971
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aimed to see if the CONNEQT Pulse blood pressure monitor gives accurate readings in pregnant women, including those with high blood pressure or pre-eclampsia. Researchers compared it to a standard blood pressure cuff in 41 pregnant volunteers. The study was stopped early, so the results are limited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CONNEQT Pulse blood pressure monitoring system
- What this could lead to
- If successful, this could provide a reliable, easy-to-use blood pressure monitor for pregnant women, helping detect conditions like pre-eclampsia earlier.
- What could go wrong
- The study was terminated early with only 41 participants, so results may not be conclusive. The device may not be as accurate as standard methods in all pregnant patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GESTATIONAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mount Carmel East
Columbus, Ohio, 43213, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can antimalarials be safely used in early pregnancy? a massive registry seeks answers
- Texts and local mentors: a new way to empower teen girls on contraception?
- Mindfulness during pregnancy: a new way to boost mental health and baby bonding?
- Teaching Moms-to-Be about seafood safety: a new weapon against toxic exposures?
- Can we improve emergency C-Sections for the sickest mothers?
- Can DIY insulin algorithms match commercial systems for pregnant women with type 1 diabetes?